CAS: 1609281-86-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | AZD3264 REF: IN-DA00ABN0CAS: 1609281-86-8 | 98% | To inquire | Mon 13 Jan 25 |
 | AZD3264 REF: TM-T6771CAS: 1609281-86-8 | 98.98% - 99.17% | 52.00 €~1,569.00 € | Tue 21 Jan 25 |
 | AZD3264 REF: 3D-JPC28186CAS: 1609281-86-8 | Min. 95% | To inquire | Mon 24 Feb 25 |
Ref: IN-DA00ABN0
| 10mg | 312.00 € | ||
| 25mg | 610.00 € | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
AZD3264
CAS:1609281-86-8
AZD3264 is a new type IKK2 inhibitor.
Formula:
C21H23N5O4S
Purity:
98.98% - 99.17%
Color and Shape:
Solid
Molecular weight:
441.5
Ref: TM-T6771
| 1mg | 52.00 € | ||
| 2mg | 70.00 € | ||
| 5mg | 102.00 € | ||
| 10mg | 159.00 € | ||
| 25mg | 308.00 € | ||
| 50mg | 496.00 € | ||
| 100mg | 795.00 € | ||
| 500mg | 1,569.00 € | ||
| 1mL*10mM (DMSO) | 113.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
AZD3264
CAS:1609281-86-8
AZD3264 is a matrix effect-based drug candidate that is currently being studied for its potential …
Formula:
C21H23N5O4S
Purity:
Min. 95%
Molecular weight:
441.5 g/mol
Ref: 3D-JPC28186
| 25mg | 1,065.00 € | ||
| 50mg | 1,482.00 € | ||
| 100mg | 2,373.00 € |
Estimated delivery in United States, on Monday 24 Feb 2025
